as posted previously.... | BNGO Message Board Posts

Bionano Genomics, Inc.

  BNGO website

BNGO   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  1314 of 1470  at  11/29/2023 10:27:07 AM  by


 In response to msg 1313 by  JoeFlow
view thread

Re: as posted previously....

 also recent news from FDA posted on biotech mb will be even more of a driver for OGM than CRISPR approaches.  I'll try to comment on this later in more detail.
All CAR-T therapies use lentivirus/retrovirus vectors for genetic engineering.  retroviruses such as HIV are RNA viruses that make a reverse transcriptase to create a DNA copy of their genome, which is inserted into the host genome.  This process can disrupt and/or mutate the function of normal/healthy genes leading to malignancies now being seen in some patients.
Thanks to lady minx for posting this on biotech mb.

FDA has determined that the risk of T-cell malignancies is applicable to all currently approved BCMA-directed and CD19-directed genetically modified autologous CAR T cell immunotherapies. T-cell malignancies have occurred in patients treated with several products in the class. Currently approved products in this class (listed alphabetically by trade name) include the following:

  • Abecma (idecabtagene vicleucel)
  • Breyanzi (lisocabtagene maraleucel)
  • Carvykti (ciltacabtagene autoleucel)
  • Kymriah (tisagenlecleucel)
  • Tecartus (brexucabtagene autoleucel)
  • Yescarta (axicabtagene ciloleucel)

Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action.


     e-mail to a friend      printer-friendly     add to library      
Recs: 4  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Financial Market Data provided by